---
title: "Multiple Sclerosis Models"
canonical: "https://www.pharmalegacy.com/indications/cns-disease-models/neurodegenerative-diseases/huntingtons-disease-models/"
lastmod: "2026-07-13T10:10:56+00:00"
generator: "llm-mirrors/1.0.19"
---

# MULTIPLE SCLEROSIS
PharmaLegacy has the expertise and models you need to advance your multiple sclerosis program.

PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR HUNTINGTON’S DISEASE PROGRAM.

✕

Let PharmaLegacy provide the answers you need.

MODELS / SERVICES

Myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in mouse

Proteolipid protein (PLP)-induced relapsing-remitting experimental autoimmune encephalomyelitis (EAE) in mouse

Myelin basic protein (MBP)-induced experimental autoimmune encephalomyelitis (EAE) in mouse

Cuprizone-induced experimental autoimmune encephalomyelitis (EAE) in mouse

Myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in cynomolgus monkey

The PharmaLegacy advantage:

We initiate most studies in under 2 weeks
Capacity for 200+ concurrent studies
Scientific staff with 15+ years of experience on average
1500+ validated animal models of disease spanning 100+ indications

See why 18 of the top 20 pharmaceutical companies trust PharmaLegacy. Contact us today.

✕

Let PharmaLegacy provide the answers you need.

We’re ready when you are.             Tell us your multiple sclerosis pipeline challenges.

+86-21-6176-5100*8051
+1-617-803-9415

info@pharmalegacy.com

✕

Csv Download